Catalytic properties of class A beta-lactamases: efficiency and diversity
- PMID: 9480862
- PMCID: PMC1219177
- DOI: 10.1042/bj3300581
Catalytic properties of class A beta-lactamases: efficiency and diversity
Erratum in
- 1998 May 1;331(Pt 3):975
Abstract
beta-Lactamases are the main cause of bacterial resistance to penicillins, cephalosporins and related beta-lactam compounds. These enzymes inactivate the antibiotics by hydrolysing the amide bond of the beta-lactam ring. Class A beta-lactamases are the most widespread enzymes and are responsible for numerous failures in the treatment of infectious diseases. The introduction of new beta-lactam compounds, which are meant to be 'beta-lactamase-stable' or beta-lactamase inhibitors, is thus continuously challenged either by point mutations in the ubiquitous TEM and SHV plasmid-borne beta-lactamase genes or by the acquisition of new genes coding for beta-lactamases with different catalytic properties. On the basis of the X-ray crystallography structures of several class A beta-lactamases, including that of the clinically relevant TEM-1 enzyme, it has become possible to analyse how particular structural changes in the enzyme structures might modify their catalytic properties. However, despite the many available kinetic, structural and mutagenesis data, the factors explaining the diversity of the specificity profiles of class A beta-lactamases and their amazing catalytic efficiency have not been thoroughly elucidated. The detailed understanding of these phenomena constitutes the cornerstone for the design of future generations of antibiotics.
Similar articles
-
Beta-lactamases and bacterial resistance to antibiotics.Mol Microbiol. 1995 May;16(3):385-95. doi: 10.1111/j.1365-2958.1995.tb02404.x. Mol Microbiol. 1995. PMID: 7565100 Review.
-
Energetic, structural, and antimicrobial analyses of beta-lactam side chain recognition by beta-lactamases.Chem Biol. 2001 Jan;8(1):17-31. doi: 10.1016/s1074-5521(00)00052-1. Chem Biol. 2001. PMID: 11182316
-
[Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].Acta Med Croatica. 2004;58(4):307-12. Acta Med Croatica. 2004. PMID: 15700687 Croatian.
-
Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.Anal Chem. 2005 Aug 15;77(16):5268-76. doi: 10.1021/ac0502605. Anal Chem. 2005. PMID: 16097768
-
SHV-type beta-lactamases.Curr Pharm Des. 1999 Nov;5(11):847-64. Curr Pharm Des. 1999. PMID: 10539992 Review.
Cited by
-
Multidrug-resistant phenotype and isolation of a novel SHV- beta-Lactamase variant in a clinical isolate of Enterobacter cloacae.J Biomed Sci. 2015 Apr 11;22(1):27. doi: 10.1186/s12929-015-0131-5. J Biomed Sci. 2015. PMID: 25888770 Free PMC article.
-
Biochemical-genetic analysis and distribution of DES-1, an Ambler class A extended-spectrum beta-lactamase from Desulfovibrio desulfuricans.Antimicrob Agents Chemother. 2002 Oct;46(10):3215-22. doi: 10.1128/AAC.46.10.3215-3222.2002. Antimicrob Agents Chemother. 2002. PMID: 12234847 Free PMC article.
-
Predicting evolutionary potential: in vitro evolution accurately reproduces natural evolution of the tem beta-lactamase.Genetics. 2002 Mar;160(3):823-32. doi: 10.1093/genetics/160.3.823. Genetics. 2002. PMID: 11901104 Free PMC article.
-
Improvement of crystal quality by surface mutations of beta-lactamase Toho-1.Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Apr 1;65(Pt 4):379-82. doi: 10.1107/S1744309109008240. Epub 2009 Mar 25. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009. PMID: 19342785 Free PMC article.
-
Ligand-dependent disorder of the Omega loop observed in extended-spectrum SHV-type beta-lactamase.Antimicrob Agents Chemother. 2011 May;55(5):2303-9. doi: 10.1128/AAC.01360-10. Epub 2011 Feb 28. Antimicrob Agents Chemother. 2011. PMID: 21357298 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous